DGAP-Gesamtstimmrechte: Elanix Biotechnologies AG

DGAP-NVR: Elanix Biotechnologies AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elanix Biotechnologies AG / Total Voting Rights Announcement

18.08.2016 12:25

Total Voting Rights Announcement according to Article 26a of the WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------------

Publication of total number of voting rights

1. Details of issuer

Elanix Biotechnologies AG c/o Rechtsanwalt Hr. Torsten Cejka, Domstrasse 22 14482 Potsdam Germany

2. Type of capital measure

Type of capital measure Date of status / date of effect Conditional capital increase (Sec. 26a para. 2 WpHG) X Other capital measure (Sec. 26a para. 1 17 Aug 2016 WpHG)

3. New total number of voting rights:

5.666.000

18.08.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

--------------------------------------------------------------------------- Language: English Company: Elanix Biotechnologies AG c/o Rechtsanwalt Hr. Torsten Cejka, Domstrasse 22 14482 Potsdam Germany Internet: End of Announcement DGAP News-Service ---------------------------------------------------------------------------